Long-term follow-up shows need for new chemotherapy strategies for rectal cancer

Results of EORTC trial 22921 at 10.4 years median follow-up Appearing in┬áLancet Oncology, long term results of EORTC trial 22921 with 10.4 years median follow-up show that 5-FU (fluorouracil) based adjuvant chemotherapy after preoperative (chemo)-radiotherapy for patients with cT3-resectable T4 M0 rectal cancer does not improve survival or disease-free survival. EORTC trial 22921 explored the … Continue reading Long-term follow-up shows need for new chemotherapy strategies for rectal cancer